SHPK: A Protein Potential Drug Target and Biomarker (G23729)

Target Name: SHPK

NCBI ID: G23729

SHPK

SHPK: A Protein Potential Drug Target and Biomarker

SHPK, or Sodium-Glucose cotransporter 2, is a protein that is expressed in most tissues in the body. It is a key component of the Na+-K+ pump, which is responsible for maintaining the electrolyte balance in the body. The SHPK gene was first identified in 2001 and has since been shown to be involved in a wide range of physiological processes, including fetal development, tissue repair, and cancer progression.

One of the most promising aspects of SHPK is its potential as a drug target. The SHPK gene has been shown to be involved in a variety of cellular processes that are important for human health, including the regulation of ion transport, cell signaling, and inflammation . Therefore, SHPK has been identified as a potential target for a variety of drugs, including small molecules, peptides, and antibodies.

One of the most promising aspects of SHPK is its potential as a drug target is its involvement in cancer progression. SHPK has been shown to be involved in the regulation of cell proliferation and has been implicated in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. Therefore, SHPK has been identified as a potential drug target for cancer treatment.

In addition to its potential as a cancer drug target, SHPK has also been shown to be involved in a variety of other cellular processes that are important for human health. For example, SHPK has been shown to be involved in the regulation of ion transport and has been implicated in the development of hyponatremia, which is characterized by low serum sodium levels. Additionally, SHPK has been shown to be involved in the regulation of cell signaling and has been implicated in the development of a variety of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Another promising aspect of SHPK is its role as a biomarker. SHPK has been shown to be expressed in a variety of tissues and has been used as a biomarker for a wide range of diseases, including cancer, neurodegenerative diseases, and liver disease. By measuring the expression of SHPK, researchers can monitor the health of tissues and identify potential biomarkers for disease.

In conclusion, SHPK is a protein that has been shown to be involved in a wide range of physiological processes that are important for human health. Its potential as a drug target and biomarker makes it an attractive target for research into the development of new therapies for a variety of diseases. Further research is needed to fully understand the role of SHPK in human health and to develop effective treatments for the diseases that are associated with its dysfunction.

Protein Name: Sedoheptulokinase

Functions: Acts as a modulator of macrophage activation through control of glucose metabolism

The "SHPK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHPK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets